Piramal Pharma Market Cap

Piramal Pharma has a market cap or net worth of 201.04 billion as of March 9, 2026. Its market cap has decreased by -17.99% in one year.

Market Cap

201.04B

Enterprise Value

242.11B

Revenue

88.71B

Ranking

n/a

PE Ratio

n/a

Stock Price

151.40

Market Cap Chart

Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 201.04B, a decrease of -11.33%. That is a compound annual growth rate of -3.49%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	201.04B	-12.08%
Dec 31, 2025	228.67B	-35.22%
Dec 31, 2024	352.98B	92.16%
Dec 29, 2023	183.69B	34.26%
Dec 30, 2022	136.81B	-39.66%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wockhardt	211.17B
Eris Lifesciences	188.49B
NATCO Pharma	182.64B
Emcure Pharmaceuticals	268.42B
Gland Pharma	274.98B
Alembic Pharmaceuticals	139.26B
Alivus Life Sciences	112.31B
Ajanta Pharma	373.66B

Market Cap Rankings